Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Revitol Cellulite Cream

What Is Prostate Cancer? What Causes Prostate Cancer?
Prostate cancer is a disease which only affects men. Cancer begins to grow in the prostate - a gland in the male reproductive system. The word "prostate" comes from Medieval Latin prostate and Medieval French prostate. The ancient Greek word prostates means "one standing in front", from proistanai meaning "set before". The prostate is so called because of its position - it is at the base of the bladder. Don't forget to buy zoloft online no prescription.

Hot Dogs Should Carry Cancer Warning Labels Says US Non Profit Group
A US non-profit organization filed a lawsuit on Wednesday asking a New Jersey county court to force food companies to put labels warning of

generic viagra online


News of the day
Medical Staff Cut Down On Hospital-Acquired Infections
CNN reports on Alfonso Torress-Cook and his efforts to eliminate fatal infections at Pacific Hospital of Long Beach, California: "Torress-Cook is part of a growing movement in medicine that no longer accepts hospital-acquired infections as inevitable complications. Every year, such infections sicken 1.7 million and kill 99,000 people in the United States."
Sexual Health

University Of Pittsburgh Cancer Institute Researcher Dr. Merrill Egorin Honored With ASCO Translational Research Professorship

Merrill Egorin, M.D., professor of medicine and pharmacology at the University of Pittsburgh Cancer Institute (UPCI), has received the 2009 American Society of Clinical Oncology (ASCO) Translational Research Professorship for his work in improving cancer treatments and supporting the next generation of researchers. The award provides $100,000 annually for five years to further the training and career development of clinical oncologists for whom translational research is the primary or major component of their professional activities. "I am tremendously honored to receive this wonderful award, which truly encourages bench-to-bedside research," said Dr. Egorin. "I"ve dedicated my career to pursuing translational research and having my efforts recognized by ASCO is both humbling and inspiring." "This award acknowledges Dr. Egorin"s lifelong dedication to improving cancer treatments and rewards his ongoing and passionate commitment to mentoring the next generation of researcher," said Nancy E. Davidson, M.D., director of UPCI and UPMC Cancer Centers. "One of the most important responsibilities for accomplished researchers is the nurturing and support of junior investigators, and no one has been more engaged in this process than Dr. Egorin." Dr. Egorin will use the professorship to continue his pre-clinical and clinical studies of inhibitors of the PARP family of enzymes and how they can be exploited as targets for cancer therapies. PARP enzymes are responsible for a variety of cellular processes, including gene regulation, replication and the maintenance of genomic stability. "The PARP family is an extremely interesting target for drug development. We already have several PARP inhibitors in early development, including several phase I trials evaluating the drug ABT-888. This award will support the expansion of the study of PARP inhibitors in cancer treatments," he said. Dr. Egorin will officially receive his award on May 31 during ASCO"s Grants and Awards ceremony. The University of Pittsburgh Cancer Institute


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009